Product NDC: | 0008-0941 |
Proprietary Name: | Protonix |
Non Proprietary Name: | PANTOPRAZOLE SODIUM |
Active Ingredient(s): | 40 mg/10mL & nbsp; PANTOPRAZOLE SODIUM |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0008-0941 |
Labeler Name: | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020988 |
Marketing Category: | NDA |
Start Marketing Date: | 20010501 |
Package NDC: | 0008-0941-03 |
Package Description: | 25 CARTON in 1 PACKAGE (0008-0941-03) > 1 VIAL in 1 CARTON (0008-0941-01) > 10 mL in 1 VIAL |
NDC Code | 0008-0941-03 |
Proprietary Name | Protonix |
Package Description | 25 CARTON in 1 PACKAGE (0008-0941-03) > 1 VIAL in 1 CARTON (0008-0941-01) > 10 mL in 1 VIAL |
Product NDC | 0008-0941 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | PANTOPRAZOLE SODIUM |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20010501 |
Marketing Category Name | NDA |
Labeler Name | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
Substance Name | PANTOPRAZOLE SODIUM |
Strength Number | 40 |
Strength Unit | mg/10mL |
Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |